$41.30

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. Please allow 4-6 weeks for production.
Sku CI02471_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Fmoc-D-valine
Brand Name
Chem Impex
Product Number
02471
CAS
84624-17-9
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
1549479
IUPAC Name
(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoic acid
InChI Key
UGNIYGNGCNXHTR-GOSISDBHSA-N
SMILES
CC(C)C@H(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Application

Fmoc-D-valine is widely utilized in research focused on

Peptide Synthesis: This compound serves as a protecting group for amino acids in solid-phase peptide synthesis, allowing for the selective modification of peptide chains without unwanted reactions.

Drug Development: Its role in creating peptide-based therapeutics is crucial, particularly in designing drugs that target specific biological pathways, enhancing efficacy and reducing side effects.

Biotechnology: Fmoc-D-valine is used in the production of recombinant proteins, aiding in the development of enzymes and antibodies for various applications in diagnostics and therapeutics.

Research in Neuroscience: This compound is instrumental in synthesizing neuropeptides, which are vital for studying neural signaling and developing treatments for neurological disorders.

Custom Peptide Libraries: It enables the creation of diverse peptide libraries for high-throughput screening, facilitating the discovery of novel compounds with potential pharmaceutical applications.

References Data Source From Pubchem

Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants

Publication Name: Nature Biomedical Engineering
Publication Date: 2025-05-29
DOI: 10.1038/s41551-025-01404-w

Accurate de novo design of heterochiral protein–protein interactions

Publication Name: Cell Research
Publication Date: 2024-08-14
DOI: 10.1038/s41422-024-01014-2

Synthesis of alamandine glycoside analogs as new drug candidates to antagonize the MrgD receptor for pain relief

Publication Name: Medicinal Chemistry Research
Publication Date: 2022-04-08
DOI: 10.1007/s00044-022-02881-3

In Vitro Evaluation and Biodistribution Studies of HPMA Copolymers Targeting the Gastrin Releasing Peptide Receptor in Prostate Cancer

Publication Name: Pharmaceutical Research
Publication Date: 2020-10-23
DOI: 10.1007/s11095-020-02952-3

A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway

Publication Name: Journal of biomolecular screening
Publication Date: 2016-07
DOI: 10.1177/1087057116635503